Bertulfo, Engracia E.
HRN: 19-04-10 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/20/2026
CEFTRIAXONE 1G (VIAL)
08/20/2026
08/26/2026
IM
2g
Od
Cap Mrs
Pending Pharmacy Acceptance
Indication: EmpiricEmpirical De-escalation Type of Infection: Pneumonia Compliance to guidelines: